TB-500 + BPC-157 Stack (5 mg Vials) Dosage Protocol
Quickstart Highlights
TB-500 (Thymosin β4) is a 43-amino-acid peptide that promotes tissue repair and regeneration through enhanced angiogenesis and cellular migration[1][2]. BPC-157 (Body Protection Compound-157) is a 15-amino-acid gastric peptide studied for accelerating musculoskeletal healing by upregulating growth factor signaling[3][4]. Stacking these peptides is a common research approach for synergistic tissue repair support.
Dosing & Reconstitution Guide
Educational guide for reconstitution and combined dosing protocol
TB-500 Protocol (2 mL Reconstitution = 2.5 mg/mL)
| Week | Dose (mcg) | Units (per injection) (mL) | Frequency |
|---|---|---|---|
| Weeks 1–4 | 1,250 mcg (1.25 mg) | 50 units (0.50 mL) | Twice weekly |
| Weeks 5–12 | 1,250 mcg (1.25 mg) | 50 units (0.50 mL) | Once weekly |
Route: Subcutaneous injection. The loading phase (Weeks 1–4) uses twice-weekly dosing to establish tissue saturation, followed by a maintenance phase (Weeks 5–12) at once weekly[1].
TB-500 Reconstitution Steps
BPC-157 Protocol (2 mL Reconstitution = 2.5 mg/mL)
| Week | Daily Dose (mcg) | Units (per injection) (mL) | Frequency |
|---|---|---|---|
| Weeks 1–2 | 250 mcg (0.25 mg) | 10 units (0.10 mL) | Once daily |
| Weeks 3–8 | 500 mcg (0.50 mg) | 20 units (0.20 mL) | Once daily |
| Weeks 9–12 | 250 mcg (0.25 mg) | 10 units (0.10 mL) | Once daily |
Route: Subcutaneous injection, preferably near the site of injury. Preclinical research commonly uses 250–500 mcg per day for musculoskeletal applications[3][4]. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.
BPC-157 Reconstitution Steps
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
Plan based on an 8–16 week combined protocol with the schedules above.
- 8 weeks ≈ 3 vials
- 12 weeks ≈ 4 vials
- 16 weeks ≈ 5 vials
- 8 weeks ≈ 5 vials
- 12 weeks ≈ 7 vials
- 16 weeks ≈ 8 vials
- 8 weeks: 68 syringes (TB-500: 12 + BPC-157: 56)
- 12 weeks: 100 syringes (TB-500: 16 + BPC-157: 84)
- 16 weeks: 132 syringes (TB-500: 20 + BPC-157: 112)
- 8 weeks (8 total vials): 16 mL → 2 × 10 mL bottles
- 12 weeks (11 total vials): 22 mL → 3 × 10 mL bottles
- 16 weeks (13 total vials): 26 mL → 3 × 10 mL bottles
- 8 weeks: ~160 swabs → recommend 2 × 100-count boxes
- 12 weeks: ~232 swabs → recommend 3 × 100-count boxes
- 16 weeks: ~304 swabs → recommend 4 × 100-count boxes
View TB-500
View BPC-157
Protocol Overview
Concise summary of the combined regimen.